Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,466 | 14,599 | 13,718 | 16,532 | 19,276 |
| TOTAL | $47,245 | $15,561 | $13,944 | $16,927 | $19,834 |
| Non-Current Assets | |||||
| PPE Net | 54 | 60 | 65 | 71 | 76 |
| Other Non-Current Assets | 313 | 312 | 312 | 312 | 312 |
| TOTAL | $367 | $372 | $377 | $383 | $388 |
| Total Assets | $47,612 | $15,933 | $14,321 | $17,310 | $20,222 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,941 | 714 | 641 | 1,196 | 1,282 |
| Accrued Expenses | 2,356 | 2,051 | 2,040 | 1,972 | 2,079 |
| TOTAL | $5,297 | $2,764 | $2,681 | $3,168 | $3,361 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 727 | 727 | 727 | 727 | 1,311 |
| TOTAL | $727 | $727 | $727 | $727 | $1,311 |
| Total Liabilities | $6,024 | $3,492 | $3,409 | $3,895 | $4,672 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,383 | 11,452 | 6,311 | 5,825 | 5,531 |
| Common Shares | 12 | 8 | 6 | 6 | 6 |
| Retained earnings | -336,929 | -333,641 | -331,186 | -328,213 | -324,975 |
| Other shareholders' equity | -11,126 | -10,635 | -10,630 | -10,628 | -10,627 |
| TOTAL | $41,588 | $12,442 | $10,913 | $13,415 | $15,550 |
| Total Liabilities And Equity | $47,612 | $15,933 | $14,321 | $17,310 | $20,222 |